The lack of an association between RANKL and BRCA breast cancer risk suggests that circulating RANKL may not be a reliable biomarker of breast cancer risk in this high-risk population, although this requires confirmation in a larger sample of women. The gene discussed is TNFSF11; the disease is breast carcinoma.